Skip to content
10-Q

Quarterly Report

SPYRE THERAPEUTICS, INC. SYRE

0001636282-25-000049

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 60.35M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $48.49M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $89.42M
Current Liabilities Q1 2025 · Mar 31, 2025 $70.68M
Current Liabilities Q1 2025 · Dec 31, 2024 $54.06M
Total Liabilities Q1 2025 · Mar 31, 2025 $87.17M
Total Liabilities Q1 2025 · Dec 31, 2024 $90.68M
Current Assets Q1 2025 · Mar 31, 2025 $569.77M
Current Assets Q1 2025 · Dec 31, 2024 $608.47M
Total Assets Q1 2025 · Mar 31, 2025 $569.78M
Total Assets Q1 2025 · Dec 31, 2024 $608.48M